We often judge a company based on its sales and earnings. However, these metrics may not be sufficient on their own. A stock might get a boost if these figures rise year over year or surpass estimates ...

Although prudent on the surface, Altria's attempts to diversify from cigarettes have fallen flat. Its $1.8 billion investment into Canada cannabis licensed producer Cronos for a 41% stake and a $12.8 ...

Focusing on downside protection, BXSL and ET offer high yields, strong coverage, ideal for income-focused investors. See why ...